Featured Post

Non-Drug Treatment for GAD: Cranial Electrotherapy Stimulation

October 25, 2026

Cranial electrotherapy stimulation reduced anxiety symptoms in pooled trials, but evidence specific to diagnosed GAD remains limited.
 Read More

Other top stories

Non-Drug Treatment for GAD: Mindfulness-Based Therapies

October 25, 2026

Non-Drug Treatment Landscape for GAD: Cognitive Therapies

October 14, 2026

GAD Is More Common in Women, but Evidence Around Pregnancy and Menopause Remains Unclear

October 14, 2026

The latest news on Psychopharmacology

Could Psilocybin Help Parkinson’s Patients, Too?

Could Psilocybin Help Parkinson’s Patients, Too?
Administration, Professional Groups Trade Barbs Over Psychotropics

Administration, Professional Groups Trade Barbs Over Psychotropics
RE104 Offers a Revolutionary Approach to Postpartum Depression

RE104 Offers a Revolutionary Approach to Postpartum Depression
Weekly Mind Reader: Clinicians Tackle Psychedelics

Weekly Mind Reader: Clinicians Tackle Psychedelics

Other stories

Negative Symptoms and Xanomeline-Trospium: What Trials and Practice Data Can and Cannot Show

October 5, 2026

Larger Response in Prominent Negative Symptoms, but No Evidence of Superiority

September 30, 2026

Two Investigational Paths in GAD: Company-Reported Results on DT120 ODT and SNTX-2643

September 29, 2026

Generalized Anxiety Disorder After 65: What the Screening Evidence Does and Does Not Cover

September 23, 2026

A Recovery Estimate Reflects Symptoms and Function, Not What the Patient Reports

September 16, 2026

A Rising Quality of Life Score Does Not Mean Improved Function

September 16, 2026

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe